Overview
Congenital hydrocephalus is a condition present at birth characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, leading to increased intracranial pressure and enlargement of the head. This occurs when the normal flow, absorption, or production of CSF is disrupted. The condition primarily affects the central nervous system and can result in progressive enlargement of the skull in infants (macrocephaly), bulging of the fontanelles, irritability, vomiting, downward deviation of the eyes ("sunset sign"), and developmental delays. Subtypes include congenital hydrocephalus due to aqueductal stenosis (Dandy-Walker malformation and other obstructive forms), as well as communicating forms where CSF absorption is impaired. Congenital hydrocephalus can occur as an isolated malformation or as part of a broader syndrome. Causes include genetic mutations (such as L1CAM mutations in X-linked hydrocephalus), neural tube defects, intrauterine infections (e.g., toxoplasmosis, cytomegalovirus), and intracranial hemorrhage. In many cases, the etiology remains unknown. If left untreated, the progressive accumulation of CSF can cause significant brain damage, cognitive impairment, motor deficits, and vision problems. The primary treatment for congenital hydrocephalus is surgical intervention. The most common procedure is the placement of a ventriculoperitoneal (VP) shunt, which diverts excess CSF from the brain ventricles to the peritoneal cavity for absorption. Endoscopic third ventriculostomy (ETV) is an alternative surgical approach, particularly for obstructive forms, which creates a new pathway for CSF drainage. Early diagnosis and treatment are critical for optimizing neurodevelopmental outcomes. Long-term follow-up is essential, as shunt complications including infection, obstruction, and over-drainage are common and may require revision surgeries. Prognosis varies widely depending on the underlying cause, severity, associated malformations, and timeliness of treatment.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital hydrocephalus.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital hydrocephalus at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital hydrocephalus.
Community
No community posts yet. Be the first to share your experience with Congenital hydrocephalus.
Start the conversation →Latest news about Congenital hydrocephalus
No recent news articles for Congenital hydrocephalus.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital hydrocephalus
What is Congenital hydrocephalus?
Congenital hydrocephalus is a condition present at birth characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, leading to increased intracranial pressure and enlargement of the head. This occurs when the normal flow, absorption, or production of CSF is disrupted. The condition primarily affects the central nervous system and can result in progressive enlargement of the skull in infants (macrocephaly), bulging of the fontanelles, irritability, vomiting, downward deviation of the eyes ("sunset sign"), and developmental delays. Subtypes include
At what age does Congenital hydrocephalus typically begin?
Typical onset of Congenital hydrocephalus is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital hydrocephalus?
25 specialists and care centers treating Congenital hydrocephalus are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.